300 related articles for article (PubMed ID: 28303545)
21. Molecular Analysis of Dihydropteroate Synthase Gene Mutations in
Tsvetkova N; Harizanov R; Rainova I; Ivanova A; Yancheva-Petrova N
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069248
[No Abstract] [Full Text] [Related]
22. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.
Dini L; du Plessis M; Frean J; Fernandez V
J Clin Microbiol; 2010 Jun; 48(6):2016-21. PubMed ID: 20351205
[TBL] [Abstract][Full Text] [Related]
23. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.
Nahimana A; Rabodonirina M; Bille J; Francioli P; Hauser PM
Antimicrob Agents Chemother; 2004 Nov; 48(11):4301-5. PubMed ID: 15504856
[TBL] [Abstract][Full Text] [Related]
24. [Research progress on genes mutations related to sulfa drug resistance in
Wang M; Zhu B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):563-569. PubMed ID: 29488726
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations.
Montesinos I; Delforge ML; Ajjaham F; Brancart F; Hites M; Jacobs F; Denis O
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):32-36. PubMed ID: 27789058
[TBL] [Abstract][Full Text] [Related]
26. Absence of Pneumocystis jirovecii dihydropteroate synthase gene mutations among samples from a group of AIDS patients in China.
Li K; He A; Cai WP; Tang XP; Zheng XY; Li ZY; Zhan XM
Scand J Infect Dis; 2009; 41(2):152-4. PubMed ID: 19085210
[TBL] [Abstract][Full Text] [Related]
27. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan.
Takahashi T; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Kitamura Y; Iwamoto A
J Med Microbiol; 2002 Jun; 51(6):510-515. PubMed ID: 12018659
[TBL] [Abstract][Full Text] [Related]
28. Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data.
Esteves F; Gaspar J; Marques T; Leite R; Antunes F; Mansinho K; Matos O
Clin Microbiol Infect; 2010 Jul; 16(7):878-84. PubMed ID: 19719744
[TBL] [Abstract][Full Text] [Related]
29. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients.
Wissmann G; Alvarez-Martinez MJ; Meshnick SR; Dihel AR; Prolla JC
J Eukaryot Microbiol; 2006; 53(4):305-7. PubMed ID: 16872298
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms associated with treatment failure and mortality in pediatric Pneumocystosis.
Singh Y; Mirdha BR; Guleria R; Kabra SK; Mohan A; Chaudhry R; Kumar L; Dwivedi SN; Agarwal SK
Sci Rep; 2019 Feb; 9(1):1192. PubMed ID: 30718779
[TBL] [Abstract][Full Text] [Related]
31. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
33. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients.
Beser J; Dini L; Botero-Kleiven S; Krabbe M; Lindh J; Hagblom P
Med Mycol; 2012 Apr; 50(3):320-3. PubMed ID: 21732748
[TBL] [Abstract][Full Text] [Related]
34. Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae.
Moukhlis R; Boyer J; Lacube P; Bolognini J; Roux P; Hennequin C
Clin Microbiol Infect; 2010 May; 16(5):501-7. PubMed ID: 19673964
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients.
Liao TY; Huang YT; Lee TF; Hsueh PR; Yu CJ; Chien JY
Int J Antimicrob Agents; 2024 Jan; 63(1):107019. PubMed ID: 37925109
[TBL] [Abstract][Full Text] [Related]
36. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations.
Hauser PM; Nahimana A; Taffe P; Weber R; Francioli P; Bille J; Rabodonirina M
Clin Infect Dis; 2010 Aug; 51(4):e28-33. PubMed ID: 20604718
[TBL] [Abstract][Full Text] [Related]
37. Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal.
Costa MC; Esteves F; Antunes F; Matos O
J Antimicrob Chemother; 2006 Dec; 58(6):1246-9. PubMed ID: 17038348
[TBL] [Abstract][Full Text] [Related]
38. [Use of restriction fragment length polymorphism to detect dihydropteroate synthase gene mutations in strains of Pneumocystis jirovecii isolated in Poland].
Gołab E
Med Dosw Mikrobiol; 2007; 59(2):177-82. PubMed ID: 17929415
[TBL] [Abstract][Full Text] [Related]
39. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype.
Valerio A; Tronconi E; Mazza F; Fantoni G; Atzori C; Tartarone F; Duca P; Cargnel A
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):521-8. PubMed ID: 17558331
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy.
Dimonte S; Berrilli F; D'Orazi C; D'Alfonso R; Placco F; Bordi E; Perno CF; Di Cave D
Infect Genet Evol; 2013 Mar; 14():68-72. PubMed ID: 23183313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
